A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy

Overview of attention for article published in Frontiers in Molecular Neuroscience, January 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 88,103 followers.

@ChariteBerlin researchers & TauRx Therapeutics @TauRx have published interesting data on the protein aggregation inhibitor drug LMTM. It decreases #Parkinsons-associated alpha synuclein inclusions in mice https://t.co/w3tjUro8IG

30 Jan 2018

Reply Repost Favourite

‘A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy’ published in @FrontNeurosci https://t.co/OL4V0YuYhJ

25 Jan 2018

Reply Repost Favourite

A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy: Karima Schwab, Silke Frahm, David Horsley, Janet E. Rickard, Valeria Melis, Elizabeth A.… h

16 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.